FIGURE 2.

Range of high* and low^† estimates of excess deaths per 1,000 ESRD patients,^§ by ESRD Network service area^¶ — United States, February 1–August 31, 2020. ESRD, end-stage renal disease. *High estimates were calculated as the difference between the observed number of deaths and the predicted number of deaths from the model, divided by the number of prevalent ESRD patients as of February 1, 2020. ^†Low estimates were calculated in a similar manner but used the upper end of the one-sided 95% prediction interval from the model in place of the mean model prediction. ^§Networks 2, 3, and 14 had the highest estimated number of excess deaths per 1,000 patients. ^¶Network 1: Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, and Vermont; Network 2: New York; Network 3: New Jersey, Puerto Rico, and U.S. Virgin Islands; Network 4: Delaware and Pennsylvania; Network 5: District of Columbia, Maryland, Virginia, and West Virginia; Network 6: Georgia, North Carolina, and South Carolina; Network 7: Florida; Network 8: Alabama, Mississippi, and Tennessee; Network 9: Indiana, Kentucky, and Ohio; Network 10: Illinois; Network 11: Michigan, Minnesota, North Dakota, South Dakota, and Wisconsin; Network 12: Iowa, Kansas, Missouri, and Nebraska; Network 13: Arkansas, Louisiana, and Oklahoma; Network 14: Texas; Network 15: Arizona, Colorado, Nevada, New Mexico, Utah, and Wyoming; Network 16: Alaska, Idaho, Montana, Oregon, and Washington; Network 17: American Samoa, Guam, Hawaii, Northern Mariana Islands, and Northern California; Network 18: Southern California